Skip to main content
. 2016 May 26;7(32):52541–52552. doi: 10.18632/oncotarget.9646

Table 1. Cancers, genes, mutations, and CRISPRs editing ability.

Cancers/ Genetic diseases Mutations that can be corrected with CRISPR/Cas9* CRISPR/Cas9 Gene targets References
Lung exon 19 deletion and L858R EGFR [11]
Breast G309A, D769H, D769Y, V777L, P780ins, V842I, and R896C and BRCA1/2 mutations HER2/Neu, BRCA [12]
Thyroid C228T and C250T TERT promoter [13]
β- Thalesemia IVS2-654 (C > T) HBB [14]
Huntington p.(Gln302) and p.(Tyr539Cys) RNF216 [15]
Limb girdle muscular dystrophies types 2B and 2D c.5713C>T; p.R1905X, and missense c.229C>T; p.R77C Dysferlin, and alpha-sarcoglycan [16]
Alzheimer's H214N, R220P Presenilin 1 [17]
*

These are only few of the representative mutations causing cancers or other genetic diseases

HHS Vulnerability Disclosure